Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of PD-1 Knockout EBV-CTLs for Advanced Stage EBV Associated Malignancies

NCT03044743 is registered in ClinicalTrials.gov with Yang Yang as lead sponsor.

NCT NCT03044743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03044743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of PD-1 Knockout EBV-CTLs for Advanced Stage EBV Associated Malignancies
Lead sponsor
Yang Yang
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 7, 2017
Completion date
March 31, 2022
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv adult hodgkin lymphoma, stage iv diffuse large b-cell lymphoma, stage iv gastric carcinoma, stage iv nasopharyngeal carcinoma, t-cell lymphoma stage iv